Updates from the 2013 European Association for the Study of the Liver (EASL) Meeting
Thursday, June 20, 2013
1:00 PM (ET), 12:00 PM (CT), 11:00 AM (MT), 10:00 AM (PT)
Assessment of Needs
IAS–USA has expanded its mission to include activities that relate to the management of viral infections other than HIV. The webinar will focus on hepatitis C virus (HCV) infection. Rapid advances in treatment are anticipated with the introduction of direct-acting antivirals (DAAs) to the HCV treatment paradigm. With the projected large increase in the number of patients who will require HCV treatment in the near future, clinicians who are experts in the complexities of antiretroviral management are uniquely well positioned to join our hepatology and gastroenterology colleagues in providing care for these patients, in what promises to be an exciting new era in HCV care.
Who Should Attend
This webinar is designed for physicians and other health care practitioners who are experienced in the principles of complex chemotherapy (eg, antiretroviral therapy) and are actively treating or will be treating patients with HCV infection.
This activity is also relevant for other practitioners including nurse practitioners and other nursing professionals, physician assistants, pharmacists, and others.
Upon completion of this IAS–USA live activity, participants will be able to:
- Describe results of phase III studies of the investigational direct-acting antiviral drugs sofosbuvir and simeprevir as part of interferon–alfa-free and interferon–alfa-sparing regimens for the treatment of chronic hepatitis C virus (HCV) infection
- Interpret data regarding use of direct-acting antiviral drugs in HCV-infected patients with cirrhosis
- List treatment options for patients in whom previous HCV therapy has failed
Individual registration is required, even if you are viewing as a group, in order to receive CME credit or a Certificate of Participation. Registration closes on Tuesday, June 18, 2013.
Certificates will be available after the completion of the evaluation and claim form.
For more information or questions, please contact the registration department at registration“at”iasusa.org or 415-544-9400.
Log-In/Adobe Connect Information
A URL and log-in instructions will be e-mailed to you 2 days prior to the live webinar date. Please bookmark this page and check back for new information.
Please listen to this training via your computer speakers and make sure your volume is properly adjusted.
If you are having trouble with the audio or connecting to Adobe Connect please contact Michelle Valderama at mvalderama"at"iasusa.org.
For additional technical support during the webinar, please visit the Adobe Connect In-Meeting support website, http://www.adobe.com/support/connect/connecthostedsupport.html
Adobe Connect System Requirements
- 1.4GHz Intel® Pentium® 4 or faster processor (or equivalent) for Microsoft® Windows® XP or Windows 7; 2GHz Pentium 4 or faster processor (or equivalent) for Windows Vista®
- Windows XP, Windows Vista, or Windows 7 (32-bit or 64-bit editions with 32-bit browser)
- 512MB of RAM (1GB recommended) for Windows XP or Windows 7; 1GB of RAM (2GB recommended) for Windows Vista
- Microsoft Internet Explorer 6 through IE 9 (32 bit only); Mozilla Firefox 3 through Firefox 7; Google Chrome
- Adobe® Flash® Player 10.1 for all users (hosts, presenters, participants, and administrators)
- 500MHz PowerPC® G3 or faster or 1.83GHz Intel Core™ Duo or faster processor
- Mac OS X v10.4, 10.5, or 10.6 (Intel); Mac OS X v10.4 (PowerPC)
- 512MB of RAM (1GB recommended) Mozilla Firefox 3 through Firefox 7; Apple Safari 4 or 5; Google Chrome
- Adobe Flash Player 10.1 for all users (hosts, presenters, participants, and administrators)
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is funded through independent, educational grants at a national level from commercial organizations that are committed to supporting high-quality continuing medical education (CME). This activity is part of a national effort that includes this and other live CME courses, live course webcasts, Cases on the Web, and Topics in Antiviral Medicine.™ In the interest of an objective, unbiased, balanced, and scientifically rigorous program, the IAS–USA seeks and pools funding from companies with competing products to support the program. These companies have no input into or control over the program content or the selection of faculty.
Gilead Sciences, Inc
Merck & Co, Inc
Salix Pharmaceuticals, Inc
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (ie, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the continuing medical education activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
Frequently Asked Questions
Is there a cost to register for the webinar?
There is no cost to register.
What happens once I register?
Registrants will receive an e-mail 2 days before the event with a web address for the webinar room. Instructions for logging into the webinar room will also be included in the e-mail.
What is the format of this webinar?
The webinar will be hosted on Adobe Connect Meeting. Adobe Connect Meeting is an online meeting platform that is compatible with Mac and Windows operating systems. To verify that you will be able to participate, we suggest that you run the simple diagnostic tests available on the Adobe Connect Meeting website. Please do this as far in advance of the session as possible. The Meeting Connection Diagnostic will test your computer for the supported version of the Flash player, a clear connection to Adobe Connect Meeting, bandwidth availability, and the latest version of the Adobe Connect Meeting add-in. Please access this test at the following link, http://arcps.adobeconnect.com/common/help/en/support/meeting_test.htm.
Audio for this event will be broadcasted over your computer speakers. Please test the volume of your computer speakers as far in advance of the session as possible.
Will I receive Continuing Medical Education (CME) credit for participating in this webinar?
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians (MDs, DOs, and international equivalents) may receive CME credit for this activity. Other health care practitioners will receive a certificate of participation.
How do I claim CME credit for participating in this webinar?
Following the webinar you will receive an e-mail with a link to the attendee evaluation form. After clicking “Submit Evaluation,” you will be redirected to the online claim form. You must log in or create an account at www.iasusa.org to claim CME credit or a Certificate of Participation.
Will the webinar be recorded?
Yes. The webinar will be recorded and archived. The recording will be available on this webpage 24 hours after the event date.
You may view or share the archived recording for educational purposes, however, it is not available for CME credit.
For more information, please contact the registration department at registration“at”iasusa.org or 415-544-9400.